Received Jan 14, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Huge black and red bruise/bruising; flu like symptoms; cold chills; body aches; Vasculitis with purpura spots all over legs; This non-serious case was reported by a consumer via other and described the occurrence of contusion in a 62-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Concomitant products included propranolol hydrochloride (Propranolol). On 30-OCT-2025, the patient received Shingles vaccine. On 31-OCT-2025, 1 days after receiving Shingles vaccine, the patient experienced contusion (Verbatim: Huge black and red bruise/bruising), influenza-like symptoms (Verbatim: flu like symptoms), chills (Verbatim: cold chills), general body pain (Verbatim: body aches) and vasculitis (Verbatim: Vasculitis with purpura spots all over legs). The outcome of the contusion, influenza-like symptoms, chills, general body pain and vasculitis were not resolved. It was unknown if the reporter considered the contusion, influenza-like symptoms, chills, general body pain and vasculitis to be related to Shingles vaccine. It was unknown if the company considered the contusion, influenza-like symptoms, chills, general body pain and vasculitis to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 08-JAN-2026 The bruise at the injection site had faded but was still visible, appearing greyish with a quarter-sized white spot in the middle. The patient wondered if they had been permanently tattooed and asked what could be done. The batch number was not provided and a request for this information has been made.
Propranolol